| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1233 | Cathepsin X Inhibitor Z9 | Novel selective reversible inhibitor of cathepsin X |
|
| DCC1234 | Cavalpha2delta-1 Ligand 16rr | Novel ligand of voltage-gated calcium channel α2δ-1 subunit (Cavα2δ-1) |
|
| DCC1235 | Cay10397 | Selective inhibitor of 15-hydroxy PGDH, significantly suppressing endogenous 11-oxo-ETE production with a corresponding increase in 11(R)-HETE |
|
| DCC1236 | Cay10398 | Isoform-selective inhibitor of histone deacetylase (HDAC1) |
|
| DCC1237 | Cay10633 | Novel potent CysLT2 receptor antagonist |
|
| DCC1238 | Caylin-1 | Novel Mdm2 inhibitor, an analog of Nutlin-3 |
|
| DCC1239 | Caylin-2 | Novel Mdm2 inhibitor, an analog of Nutlin-3 |
|
| DCC1240 | Cb14171361 | Novel RAF kinase inhibitor |
|
| DCC1241 | Cb14280993 | Novel SRC kinase inhibitor |
|
| DCC1242 | Cb15143266 | Novel IκB kinase inhibitor |
|
| DCC1243 | Cb17846240 | Novel Thymidine kinase (TK) inhibitor |
|
| DCC1244 | Cb20372475 | Novel Cyclin-dependent kinase inhibitor |
|
| DCC1245 | Cb28324237 | Novel IκB kinase inhibitor |
|
| DCC1246 | Cb300919 | Novel Cell_cycle>cell cycle inhibitor |
|
| DCC1247 | cb3717 | Dual thymidylate synthase and dihydrofolate reductase inhibitor |
|
| DCC1248 | Cb5255829 | Novel inhibitor of Mycobacterium marinum MelF (Rv1936), exhibiting bacteriostatic/bactericidal activity against M. marinum and M. tuberculosis in vitro |
|
| DCC1249 | cb5468139 | Selective sphingosine kinase 1 (SK1) inhibitor |
|
| DCC1250 | Cb5660386 | Novel inhibitor of HIV-1 entry |
|
| DCC1251 | Cb6513745 | Novel inhibitor of Mycobacterium marinum MelF (Rv1936), exhibiting bacteriostatic/bactericidal activity against M. marinum and M. tuberculosis in vitro |
|
| DCC1252 | Cb7833407 | Selective inhibitor of Adenylyl Cyclase isoform-2 (AC2) |
|
| DCC1253 | Cb-892 | Novel inhibitor of HIV-1 gene expression |
|
| DCC1254 | Cb9029936 | Novel potent inhibitor of filamentation and biofilm formation by the Candida albicans SC5314 strain |
|
| DCC1255 | Cb9125618 | Novel inhibitor of Mycobacterium marinum MelF (Rv1936), exhibiting bacteriostatic/bactericidal activity against M. marinum and M. tuberculosis in vitro |
|
| DCC1256 | Cb97929926 | Novel Protein kinase A and B inhibitor |
|
| DCC1257 | Cbap-bpyne | The first clickable, photoreactive probe that inhibits both γ-secretase and PSase activities and specifically labels PS1-NTF and signal peptide peptidase (SPP) |
|
| DCC1258 | Cbb1007 | Novel cell-permeable, potent, reversible, and substrate competitive LSD1 inhibitor, promoting the adipogenic differentiation of hESCs |
|
| DCC1259 | Cbl0100 | Novel inhibitor of viral transcriptional elongation, blocking both HIV-1 replication and reactivation |
|
| DCC1260 | CBL0137 hydrochloride Featured | CBL0137 (CBL-0137) activates p53 and inhibits NF-kB with EC50s of 0.37 μM and 0.47 μM in the cell-based p53 and NF-kB reporter assays, respectively. It also inhibits histone chaperone FACT (facilitates chromatin transcription complex). |
|
| DCC1261 | Cbn207192 | Novel selective inhibitor of KDM4s, inhibiting all members of the KDM4(A-E) subfamily |
|
| DCC1262 | Cbn209350 | Novel KDM4 inhibitor, inhibiting equally all members of the KDM4 family and exhibiting modest selectivity over other JmjC-KDMs including KDM2A and PHF8 |
|
